Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine
In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019

Read at Hindustan Times(opens in a new tab)
Full coverage
Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine (opens Hindustan Times in a new tab)
In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019


